SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-212594
Filing Date
2019-08-05
Accepted
2019-08-05 09:14:03
Documents
7
Period of Report
2019-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d717626d8k.htm 8-K 22559
2 EX-5.1 d717626dex51.htm EX-5.1 9530
3 EX-10.1 d717626dex101.htm EX-10.1 153909
4 EX-99.1 d717626dex991.htm EX-99.1 9420
5 GRAPHIC g717626g0803220338438.jpg GRAPHIC 802
6 GRAPHIC g717626g71p48.jpg GRAPHIC 2595
7 GRAPHIC g717626g98i90.jpg GRAPHIC 3037
  Complete submission text file 0001193125-19-212594.txt   205940
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 19997706
SIC: 2834 Pharmaceutical Preparations